lucanthone hydrochloride has been researched along with Co-infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cose, S; Driciru, E; Elliott, AM; Koopman, JPR; Roestenberg, M; Siddiqui, AA; Yazdanbakhsh, M | 1 |
| Abdel-Rahman, M; El Raziky, M; El-Akel, W; El-Sayed, M; Elsharkawy, A; Esmat, G; Ghoneim, H; Khattab, H | 1 |
1 review(s) available for lucanthone hydrochloride and Co-infection
| Article | Year |
|---|---|
Immunological Considerations for
Topics: Animals; Coinfection; Drug Design; Drug Development; Endemic Diseases; Host-Parasite Interactions; Humans; Immunogenicity, Vaccine; Praziquantel; Protozoan Vaccines; Schistosoma; Schistosomiasis; Schistosomicides | 2021 |
1 other study(ies) available for lucanthone hydrochloride and Co-infection
| Article | Year |
|---|---|
Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response.
Topics: Adult; Antiviral Agents; Chi-Square Distribution; Coinfection; Drug Therapy, Combination; Egypt; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Liver Cirrhosis; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Polyethylene Glycols; Praziquantel; Recombinant Proteins; Retrospective Studies; Ribavirin; Risk Factors; Schistosomiasis; Schistosomicides; Time Factors; Treatment Outcome | 2013 |